{"id":2429,"date":"2025-12-09T11:18:58","date_gmt":"2025-12-09T11:18:58","guid":{"rendered":"https:\/\/www.iforbes.cz\/?p=2429"},"modified":"2025-12-09T11:18:58","modified_gmt":"2025-12-09T11:18:58","slug":"eli-lilly-snizuje-ceny-zepboundu-oslabi-tento-krok-vysledne-trzby","status":"publish","type":"post","link":"https:\/\/www.iforbes.cz\/index.php\/2025\/12\/09\/eli-lilly-snizuje-ceny-zepboundu-oslabi-tento-krok-vysledne-trzby\/","title":{"rendered":"Eli Lilly sni\u017euje ceny Zepboundu. Oslab\u00ed tento krok v\u00fdsledn\u00e9 tr\u017eby?"},"content":{"rendered":"\n<p><strong>Na poli rychle rostouc\u00edho trhu s l\u00e9ky na obezitu provedla Eli Lilly, nejhodnotn\u011bj\u0161\u00ed zdravotnick\u00e1 firma na sv\u011bt\u011b, dal\u0161\u00ed v\u00fdznamn\u00fd krok. Spole\u010dnost ozn\u00e1mila, \u017ee na platform\u011b LillyDirect od 1. prosince sn\u00ed\u017eila ceny sv\u00e9ho l\u00e9ku Zepbound ve form\u011b jednor\u00e1zov\u00fdch injek\u010dn\u00edch st\u0159\u00edka\u010dek. C\u00edl je jasn\u00fd \u2013 v\u00fdrazn\u011b roz\u0161\u00ed\u0159it dostupnost pro pacienty, zejm\u00e9na v prost\u0159ed\u00ed, kde v\u011bt\u0161ina americk\u00fdch pojistn\u00fdch pl\u00e1n\u016f l\u00e9\u010dbu obezity st\u00e1le nepokr\u00fdv\u00e1. Jak na to reagovala cena akci\u00ed?<\/strong><\/p>\n\n\n\n<p><strong>Sn\u00ed\u017een\u00ed cen<\/strong><\/p>\n\n\n\n<p>Nov\u00e9 ceny Zepboundu p\u0159edstavuj\u00ed redukci o 50 a\u017e 100 USD m\u011bs\u00ed\u010dn\u011b v z\u00e1vislosti na d\u00e1vce. \u00davodn\u00ed d\u00e1vka klesla ze 349 na 299 USD, st\u0159edn\u00ed d\u00e1vka na 399 USD a v\u0161echny vy\u0161\u0161\u00ed d\u00e1vky na 449 USD, co\u017e p\u0159edstavuje sn\u00ed\u017een\u00ed z p\u0159edchoz\u00ed ceny 499 USD. Ve srovn\u00e1n\u00ed s ofici\u00e1ln\u00ed cenou l\u00e9ku pro velkoobchodn\u00edky, p\u0159ibli\u017en\u011b 1 086 USD za m\u011bs\u00edc, jde tedy o v\u00fdraznou slevu, kter\u00e1 bohu\u017eel reaguje na aktu\u00e1ln\u00ed realitu trhu \u2013 velk\u00e1 \u010d\u00e1st pacient\u016f si GLP-1 l\u00e9\u010dbu plat\u00ed v hotovosti, proto\u017ee jejich poji\u0161t\u011bn\u00ed ji nepropl\u00e1c\u00ed.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><img loading=\"lazy\" width=\"605\" height=\"419\" src=\"https:\/\/www.iforbes.cz\/wp-content\/uploads\/2025\/12\/image-4.png\" alt=\"Obsah obr\u00e1zku text, \u0159ada\/pruh, Vykreslen\u00fd graf, P\u00edsmo\n\nObsah generovan\u00fd pomoc\u00ed AI m\u016f\u017ee b\u00fdt nespr\u00e1vn\u00fd.\" class=\"wp-image-2430\" srcset=\"https:\/\/www.iforbes.cz\/wp-content\/uploads\/2025\/12\/image-4.png 605w, https:\/\/www.iforbes.cz\/wp-content\/uploads\/2025\/12\/image-4-300x208.png 300w, https:\/\/www.iforbes.cz\/wp-content\/uploads\/2025\/12\/image-4-392x272.png 392w, https:\/\/www.iforbes.cz\/wp-content\/uploads\/2025\/12\/image-4-130x90.png 130w, https:\/\/www.iforbes.cz\/wp-content\/uploads\/2025\/12\/image-4-600x417.png 600w\" sizes=\"(max-width: 605px) 100vw, 605px\" \/><figcaption>V\u00fdkonnost ceny akci\u00ed spole\u010dnosti Eli Lilly za posledn\u00edch p\u011bt let * Zdroj: TradingEconomics<\/figcaption><\/figure><\/div>\n\n\n\n<p>Naopak z investi\u010dn\u00edho hlediska je d\u016fle\u017eit\u00e9 pod\u00edvat se na situaci i ze strany Eli Lilly. Platforma LillyDirect toti\u017e v distribuci l\u00e9\u010div hraje st\u00e1le d\u016fle\u017eit\u011bj\u0161\u00ed roli, co\u017e potvrzuj\u00ed p\u0159edev\u0161\u00edm ofici\u00e1ln\u00ed \u00fadaje spole\u010dnosti \u2013 v\u00edce ne\u017e t\u0159etina nov\u00fdch recept\u016f na Zepbound poch\u00e1z\u00ed pr\u00e1v\u011b z tohoto direct-to-consumer kan\u00e1lu. Sn\u00ed\u017een\u00ed cen tak zp\u0159\u00edstup\u0148uje l\u00e9k i dom\u00e1cnostem s ni\u017e\u0161\u00edmi p\u0159\u00edjmy a z\u00e1rove\u0148 efektivn\u011b posiluje i vlastn\u00ed prodejn\u00ed ekosyst\u00e9m. Sou\u010dasn\u011b, ni\u017e\u0161\u00ed ceny sice znamenaj\u00ed ni\u017e\u0161\u00ed v\u00fdnos na d\u00e1vku, ale trh s GLP-1 l\u00e9ky roste tak rychle, \u017ee celkov\u00e9 tr\u017eby pokra\u010duj\u00ed v robustn\u00edm r\u016fstu.<\/p>\n\n\n\n<p><strong>Vliv Donalda Trumpa<\/strong><\/p>\n\n\n\n<p>V neposledn\u00ed \u0159ad\u011b p\u0159ich\u00e1z\u00ed sn\u00ed\u017een\u00ed cen kr\u00e1tce pot\u00e9, co administrativa prezidenta Donalda Trumpa ozn\u00e1mila nov\u00e9 dohody s Eli Lilly a Novo Nordisk. Dohody maj\u00ed zlep\u0161it dostupnost GLP-1 l\u00e9k\u016f pro Ameri\u010dany, zejm\u00e9na ty v seniorsk\u00e9 programu Medicare. Je v\u0161ak d\u016fle\u017eit\u00e9 dodat, \u017ee tyto dohody se t\u00fdkaj\u00ed Zepboundu ve form\u011b v\u00edced\u00e1vkov\u00e9ho pera, kter\u00e9 teprve \u010dek\u00e1 na schv\u00e1len\u00ed \u00da\u0159adem pro kontrolu potravin a l\u00e9\u010div (FDA). V souvislosti s t\u00edm bude Medicare od ledna poprv\u00e9 v historii \u010d\u00e1ste\u010dn\u011b pokr\u00fdvat l\u00e9ky na obezitu pro vybran\u00e9 skupiny pacient\u016f.<\/p>\n\n\n\n<p><strong>V\u00fdkonnost na burze<\/strong><\/p>\n\n\n\n<p>Po ozn\u00e1men\u00ed sn\u00ed\u017een\u00ed cen akcie Eli Lilly kr\u00e1tkodob\u011b klesly o p\u0159ibli\u017en\u011b 2 %. Z dlouhodob\u011bj\u0161\u00edho hlediska v\u0161ak jde jen o minim\u00e1ln\u00ed pohyb. Spole\u010dnost m\u00e1 za sebou mimo\u0159\u00e1dn\u011b siln\u00fd rok r\u016fstu \u2013 hodnota investic akcion\u00e1\u0159\u016f stoupla o v\u00edce ne\u017e 36 %, co\u017e Eli Lilly pomohlo st\u00e1t se prvn\u00ed zdravotnickou firmou v historii, kter\u00e1 dos\u00e1hla 1bilionov\u00e9 tr\u017en\u00ed kapitalizace.<\/p>\n\n\n\n<p><strong>Tlak konkurence a budoucnost<\/strong><\/p>\n\n\n\n<p>V z\u00e1v\u011bru je stejn\u011b d\u016fle\u017eit\u00e9 dodat, \u017ee Eli Lilly nen\u00ed jedinou firmou, kter\u00e1 m\u011bn\u00ed cenovou strategii. Novo Nordisk, v\u00fdrobce Wegovy a Ozempicu, ji\u017e d\u0159\u00edve ozn\u00e1mil v\u00fdrazn\u00e9 sn\u00ed\u017een\u00ed cen \u2013 konkr\u00e9tn\u011b z 499 na 349 USD \u2013, p\u0159i\u010dem\u017e nov\u00ed pacienti mohou b\u011bhem prvn\u00edch dvou m\u011bs\u00edc\u016f zaplatit za dva nejni\u017e\u0161\u00ed objemy d\u00e1vek pouze 199 USD. Ob\u011b firmy se tak p\u0159ipravuj\u00ed na extr\u00e9mn\u011b konkuren\u010dn\u00ed boj o spot\u0159ebitele, jejich\u017e po\u010det se podle odhad\u016f analytik\u016f JPMorgan m\u016f\u017ee v n\u00e1sleduj\u00edc\u00edch letech v\u00fdrazn\u011b zv\u00fd\u0161it.<\/p>\n\n\n\n<p><strong>Anna \u0160uhajdov\u00e1, p\u0159edsedkyn\u011b p\u0159edstavenstva <\/strong><a href=\"https:\/\/www.capitalmarkets.sk\/cs\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>CAPITAL MARKETS, o.c.p., a.s.<\/strong><\/a><\/p>\n\n\n\n<p><em>Foto: AdobeStock<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Na poli rychle rostouc\u00edho trhu s l\u00e9ky na obezitu provedla Eli Lilly, nejhodnotn\u011bj\u0161\u00ed zdravotnick\u00e1 firma na sv\u011bt\u011b, dal\u0161\u00ed v\u00fdznamn\u00fd krok.<\/p>\n","protected":false},"author":1,"featured_media":2431,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_container_layout":"default_layout","colormag_page_sidebar_layout":"default_layout"},"categories":[58],"tags":[350,335,534,190,535,448],"_links":{"self":[{"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/posts\/2429"}],"collection":[{"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/comments?post=2429"}],"version-history":[{"count":1,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/posts\/2429\/revisions"}],"predecessor-version":[{"id":2432,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/posts\/2429\/revisions\/2432"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/media\/2431"}],"wp:attachment":[{"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/media?parent=2429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/categories?post=2429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/tags?post=2429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}